The FDA recognizes the increased demand for albuterol products during the novel #COVID19 pandemic. Today we approved a first generic of Proventil HFA metered dose inhaler. https://go.usa.gov/xvjP9 pic.twitter.com/tdSL55D5nT
The FDA recognizes the increased demand for albuterol products during the novel #COVID19 pandemic. Today we approved a first generic of Proventil HFA metered dose inhaler. https://go.usa.gov/xvjP9 pic.twitter.com/tdSL55D5nT
Source: Food and Drug Adminstration (FDA): CDRHNew - Category: Medical Devices Authors: ( at SteveFDA) Source Type: news